Weiser, T., Schepers, C., Mück, T., & Lange, R. (2019). Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed‐Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions—Data From 2 Single‐Center, Single‐Dose, Randomized Crossover Studies in Healthy Volunteers. Clin Pharmacol Drug Dev.
Citación estilo ChicagoWeiser, Thomas, Cornelia Schepers, Tobias Mück, y Robert Lange. "Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed‐Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU As Acid or Lysinate Under Fasted and Fed Conditions—Data From 2 Single‐Center, Single‐Dose, Randomized Crossover Studies in Healthy Volunteers." Clin Pharmacol Drug Dev 2019.
Cita MLAWeiser, Thomas, Cornelia Schepers, Tobias Mück, y Robert Lange. "Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed‐Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU As Acid or Lysinate Under Fasted and Fed Conditions—Data From 2 Single‐Center, Single‐Dose, Randomized Crossover Studies in Healthy Volunteers." Clin Pharmacol Drug Dev 2019.